Innovative Medical Device: DeepClue-Precise and Its Impact on Stroke Diagnosis

DeepClue, a company focusing on precision medical solutions, recently announced that its product, DeepClue-Precise, has been designated as an innovative medical device by South Korea’s Ministry of Food and Drug Safety (MFDS). This recognition is significant because it showcases how this technological advancement can aid the diagnosis and treatment of ischemic cerebrovascular conditions. Here’s how it aims to transform healthcare.

What Makes an Innovative Medical Device?

Innovative medical devices incorporate cutting-edge technologies like ICT and robotics. They improve the safety and effectiveness of existing medical equipment and treatments. This designation allows for a fast-tracked approval process, facilitating quicker market entry.

DeepClue-Precise: A Closer Look

DeepClue-Precise is designed specifically for patients suffering from ischemic cerebrovascular diseases. It works by generating hemodynamic and vascular images optimized for these conditions. Here’s what it offers:

• Uses CT and MR imaging technologies to reconstruct existing scans for better insights
• Provides detailed collateral blood flow imaging across various vascular phases
• Includes 3D and 4D color images to accurately evaluate the causes of ischemic conditions

How It Works

The solution utilizes several types of imaging:

1. CT Perfusion Imaging
2. MR Perfusion Imaging
3. Dynamic MR Angiography

These are reconstructed to provide detailed visuals of collateral blood flow, showing when and how much blood reaches the ischemic areas.

Unique Features of DeepClue-Precise

According to DeepClue representatives, the technology captures all necessary vascular images with a single scan. This capability can potentially:

• Enhance diagnosis accuracy
• Improve treatment planning efficiency

Commercialization and Growth

DeepClue was founded to bring DeepClue-Precise to the market. The company emphasizes that their technology is unique globally and promises rapid, precise evaluations of collateral flow indicators, initial stroke areas, ischemic penumbra, and causal vessels. The company is currently focusing on:

• Research and Development (R&D) for commercialization
• Global market entry bolstered by its innovative device designation

Future Prospects

With its innovative designation, DeepClue anticipates quicker market entry and expanded global reach. The company’s participation in the 40th International Medical Device and Hospital Equipment Exhibition (KIMES 2025) underscores its commitment to influencing stroke diagnostics on a wider scale.

Contact Information

For more information, you may refer to the official announcements from DeepClue or visit industry exhibitions where they showcase their groundbreaking technologies. By keeping abreast of such advancements, you can better understand the future direction of medical diagnostics and treatments.

Table of Contents

1. Introduction
   • MFDS Innovation Designation
   • Significance for Stroke Diagnostics
2. What Makes an Innovative Medical Device?
   • Definition and Criteria
   • Fast‑Track Approval Process
3. DeepClue‑Precise: A Closer Look
   • Target Indication: Ischemic Cerebrovascular Diseases
   • Core Technologies: CT & MR Imaging Reconstruction
   • 3D/4D Vascular Visualization
4. How It Works
   • CT Perfusion Imaging
   • MR Perfusion Imaging
   • Dynamic MR Angiography
5. Unique Features of DeepClue‑Precise
   • Single‑Scan Comprehensive Imaging
   • Collateral Blood Flow Analysis
   • Diagnostic and Treatment Planning Benefits
6. Commercialization and Growth
   • R&D and Market Preparation
   • Innovative Device Designation Benefits
   • Showcase at KIMES 2025
7. Future Prospects
   • Accelerated Global Market Entry
   • Long‑Term Impact on Stroke Care
8. Conclusion & Next Steps
   • Summary of Clinical Advantages
   • How to Learn More and Get Involved